Skip to main content

Table 2 Overview of contemporary data on the impact of comprehensive / mandated IVF insurance coverage

From: Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment

Variable

Comprehensive / Mandated IVF coverage

Non-comprehensive / Non-mandated

P-value

Data Year

Source

Utilization

  Per capita IVF utilizationa

6.2 per 1,000

women ages 25–44

2.7 per 1,000

women ages 25–44

p < .001

2018

Peipert et al. 2022 [39]

Practice Patterns

  Embryos per transfera

1.30

1.36

p < .001

2018

Peipert et al. 2022 [39]

  Frozen embryo transfer

66.1%

76.3%

p <. 001

2018

Peipert et al. 2022 [39]

  ICSI utilizaitonb

62.5%

67.6%

p =. 06

2016

Zagadailov et al. 2020 [40]

  PGT utilizationc

19.6%

27.6%

p < .001

2014–2016

Bedrick et al. 2022 [41]

Outcomes

  Live birth ratea

35.4%

33.4%

p < .001

2018

Peipert et al. 2022 [39]

  Multiple birth ratea

10.2%

13.8%

p < .001

2018

Peipert et al. 2022 [39]

  1. aIncludes all nondonor cycles reported to the CDC in 2018; comprehensive group included Connecticut, Illinois, Massachusetts, Maryland, New Jersey, and Rhode Island
  2. bAmong fresh nondonor cycles; Arkansas and Hawaii additionally included in comprehensive group
  3. cAmong non-banking cycles; Arkansas, Hawaii, Montana, Ohio, and West Virginia additionally included in mandate group